Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NMRA - Neumora Therapeutics Inc.


IEX Last Trade
11.52
0.310   2.691%

Share volume: 325,617
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$11.21
0.31
2.77%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-1.54%
1 Month
-10.23%
3 Months
18.68%
6 Months
-34.99%
1 Year
-29.23%
2 Year
-29.23%
Key data
Stock price
$11.52
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$8.33 - $21.00
52 WEEK CHANGE
-$0.29
MARKET CAP 
1.840 B
YIELD 
N/A
SHARES OUTSTANDING 
160.028 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
BETA 
1.17
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$350,319
AVERAGE 30 VOLUME 
$426,890
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news